Trial · NCT04517864
Participant flow27
How many started, completed or left each group, period by period.
1 to 20 of 27
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Placebo-Controlled Phase | STARTED | Ritlecitinib 200/50/50 mg QD | 36 | |
| Placebo-Controlled Phase | STARTED | Placebo -> Ritlecitinib 200/50 mg QD | 35 | |
| Placebo-Controlled Phase | STARTED | Ritlecitinib 50 mg QD | 0 | |
| Placebo-Controlled Phase | COMPLETED | Ritlecitinib 200/50/50 mg QD | 32 | |
| Placebo-Controlled Phase | COMPLETED | Placebo -> Ritlecitinib 200/50 mg QD | 33 | |
| Placebo-Controlled Phase | COMPLETED | Ritlecitinib 50 mg QD | 0 | |
| Placebo-Controlled Phase | NOT COMPLETED | Ritlecitinib 200/50/50 mg QD | 4 | |
| Placebo-Controlled Phase | NOT COMPLETED | Placebo -> Ritlecitinib 200/50 mg QD | 2 | |
| Placebo-Controlled Phase | NOT COMPLETED | Ritlecitinib 50 mg QD | 0 | |
| Active Therapy Extension Phase | STARTED | Ritlecitinib 200/50/50 mg QD | 32 | |
| Active Therapy Extension Phase | STARTED | Placebo -> Ritlecitinib 200/50 mg QD | 33 | |
| Active Therapy Extension Phase | STARTED | Ritlecitinib 50 mg QD | 0 | |
| Active Therapy Extension Phase | COMPLETED | Ritlecitinib 200/50/50 mg QD | 21 | |
| Active Therapy Extension Phase | COMPLETED | Placebo -> Ritlecitinib 200/50 mg QD | 24 | |
| Active Therapy Extension Phase | COMPLETED | Ritlecitinib 50 mg QD | 0 | |
| Active Therapy Extension Phase | NOT COMPLETED | Ritlecitinib 200/50/50 mg QD | 11 | |
| Active Therapy Extension Phase | NOT COMPLETED | Placebo -> Ritlecitinib 200/50 mg QD | 9 | |
| Active Therapy Extension Phase | NOT COMPLETED | Ritlecitinib 50 mg QD | 0 | |
| Extension Phase | STARTED | Ritlecitinib 200/50/50 mg QD | 0 | |
| Extension Phase | STARTED | Placebo -> Ritlecitinib 200/50 mg QD | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04517864/flow